These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13034908)

  • 1. Endocrine therapy in the management of prostatic cancer.
    HECKEL NJ
    J Clin Endocrinol Metab; 1953 Feb; 13(2):228-30. PubMed ID: 13034908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer of the lung metastatic from the prostate; disappearance of the radiological images after diethylstilbestrol therapy].
    MEYER A; HINAUT G; LIOT F
    Bull Mem Soc Med Hop Paris; 1951 Oct 19-26; 67(27-28):1190-5. PubMed ID: 14925878
    [No Abstract]   [Full Text] [Related]  

  • 3. Biologic titration of diethylstilbestrol against activity of prostatic cancer: effect on serum aldolase.
    BAKER R; GOVAN D; HUFFER J; CASON J
    J Clin Endocrinol Metab; 1953 Apr; 13(4):383-91. PubMed ID: 13052668
    [No Abstract]   [Full Text] [Related]  

  • 4. The question of stilbestrol in the treatment of prostatic carcinoma.
    Lawrence W; Horsley JS
    Va Med Mon (1918); 1968 Apr; 95(4):238-40. PubMed ID: 5645075
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine manipulation of the Dunning prostatic adenocarcinoma.
    Shessel FS; Block NL; Stover B; Claflin A; Malinin TI; Politano VA
    Invest Urol; 1980 May; 17(6):529-33. PubMed ID: 7372443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary cancer of the lung of prostatic origin; recovery maintained for 3 years by diethylstilbestrol therapy].
    MEYER A; LIOT F
    Bull Mem Soc Med Hop Paris; 1954 Mar 26-Apr 9; 70(11-12):401-4. PubMed ID: 13172629
    [No Abstract]   [Full Text] [Related]  

  • 7. Resolution of hepatic metastases from carcinoma of prostate with stilbestrol.
    Blyth B; McRae CU; Turner JG
    Urology; 1991 Jun; 37(6):574-5. PubMed ID: 2038795
    [No Abstract]   [Full Text] [Related]  

  • 8. Endocrine inhibition as related to carcinoma of the prostate.
    VALK WL; OWENS RH
    J Urol; 1954 Sep; 72(3):516-24. PubMed ID: 13202240
    [No Abstract]   [Full Text] [Related]  

  • 9. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine therapy of prostate cancer 1945-47].
    BOJSEN F
    Ugeskr Laeger; 1954 Jul; 116(27):1010-4. PubMed ID: 13196179
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostatic cancer. III. Advantages of large oral dosage of diethylstilbestrol.
    FISH GW; HUDSON PB; JOST HM
    J Urol; 1954 Dec; 72(6):1222-3. PubMed ID: 13212944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diethyl-stilbestrol for treatment of prostatic carcinoma].
    Cifuentes Delatte L
    Arch Esp Urol; 1990 Sep; 43(7):697-704. PubMed ID: 2125823
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of orchiectomy and various doses of stilbestrol on plasma testosterone levels in patients with carcinoma of the prostate.
    Mackler MA; Liberti JP; Smith MJ; Koontz WW; Prout GR
    Invest Urol; 1972 Mar; 9(5):423-5. PubMed ID: 5016026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diethylstilbestrol-induced liver cancer?].
    Rosinus V; Maurer R
    Schweiz Med Wochenschr; 1981 Jul; 111(30):1139-42. PubMed ID: 6267685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of clinically localized prostatic cancer--endocrine therapy].
    Hirano A
    Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic aspects in the treatment of prostatic cancer.
    HASCHE-KLUNDER R; WILMANNS H
    Br J Urol; 1957 Mar; 29(1):20-4. PubMed ID: 13413208
    [No Abstract]   [Full Text] [Related]  

  • 18. Massive pleural effusions from prostatic lymphangitic carcinomatosis: resolution with endocrine therapy.
    Heffner JE; Duffey DJ; Schwarz MI
    Arch Intern Med; 1982 Feb; 142(2):375-6. PubMed ID: 7059263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of conservative therapy in prostate carcinoma].
    PAGEL W
    Z Urol; 1957; 50(12):681-8. PubMed ID: 13531567
    [No Abstract]   [Full Text] [Related]  

  • 20. Planned cytostatic therapy of carcinoma of the prostate.
    WARNECKE CE
    Bruns Beitr Klin Chir; 1955 May; 190(3):341-8. PubMed ID: 14389781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.